Skip to main content
. 2025 Apr 15;26(8):3737. doi: 10.3390/ijms26083737
KI Kinase inhibitors
MKI Multi kinase inhibitor
RTK Receptor tyrosine kinase
VEGF Vascular Endothelial Growth Factor
TTFields Tumor Treatment Fields
PKA Cyclic-AMP-dependent protein kinase
EGFR Epidermal Growth Factor Receptor
FGFR Fibroblast Growth Factor Receptor
EGFR Epidermal Growth Factor Receptor
NSCLS Non small cell lung cancer
TGF-α Transforming Growth Factor alpha
HB-EGF Heparin-binding EGF-like Growth Factor
MAPK Mitogen-Activated Protein Kinase
NSCLC Non Small Cell Lung Cancer
OS Overall Survival
BBB Blood–Brain Barrier
PDGF Platelet-Derived Growth Factor
PDGFR Platelet-Derived Growth Factor Receptor
VEGFR1-3 Vascular Endothelial Growth Factor Receptors 1, 2 and 3
TIS Therapy-Induced Senescence
GSC Glioma Stem Cell
ROS Reactive Oxygen Species
ATM Ataxia Telangectasia Mutated
HIF 1 α Hypoxia inducible factor 1α
CDKN1A Cyclin dependent kinase inhibitor 1A
FFPE Formalin fixed paraffin embedded
PSAT1 Phosphoserine aminotransferase 1